Reeves’ Autumn Budget targets community health centres and NHS tech outlay
During the UK’s Autumn Budget, Rachel Reeves has unveiled further technology investments for the UK’s National Health Service (NHS) and,…
All articles by Ross Law
Ross Law
Ross Henry Law is a reporter for Medical Device Network. His key interest areas in healthcare include regulation, mental health, neurology, oncology, and Alzheimer's disease. Ross also has extensive prior experience in covering the captive insurance, retail, and technology sectors.
-
-
Sophia Genetics and Element partner to advance precision medicine research
Sophia Genetics and Element Biosciences have teamed up to advance genomic sequencing and workflows for precision medicine. Announced during the…
-
MMI wins IDE for surgical robotic Alzheimer’s disease study
US-based robotics company Medical Microinstruments (MMI) has obtained an investigational device exemption (IDE) from the US Food and Drug Administration…
-
The early phase advantage: the key to de-risking your clinical trials
In drug development, the earliest phases carry both the greatest uncertainty and the greatest opportunity. Early phase clinical trials, whether…
-
BCI implant’s trial success prefigures ‘new era’ in eye care
An electronic eye implant is giving hope to individuals who have experienced visual impairment due to dry age-related macular degeneration…
-
FDA greenlight for Roche’s Alzheimer’s disease test sparks care paradigm shift
The US Food and Drug Administration’s (FDA) recent clearance of Roche’s blood-based Alzheimer’s disease test will boost therapeutic intervention options…
-
Advancing patient registries and expanding real world evidence through technology
Patient registries are evolving from static data repositories to become valuable sources of real world evidence (RWE), which is increasingly…
-
US Government shuts down over funding impasse
The US Government has shut down for the first time since 2018 after a majority of Democrat senators refused to…
-
What clinical trial sponsors need to know about anonymisation and pseudonymisation of data
With the healthcare industry relying heavily on data for medical research and surveillance studies, it is critically important that sponsors,…
-
Reflexive CRO decisions are costing sponsors
Unlike your TV remote control, big business decisions don’t come with a rewind button. In the world of large clinical…